As more AI-driven healthcare products are brought to market, how can regulators keep pace with this rapidly evolving technology?
Artificial intelligence (AI) is becoming a force to be reckoned with in healthcare. Over the last decade or so, AI-based healthcare products have moved out of the proof-of-concept stage and have begun to rewrite our understanding of what might be possible.
To cite just a few examples: deep learning techniques have been used in dermatology to diagnose skin cancer, and in radiology to make better sense of CT scans. Surgeons are using robots integrated with AI, while pharma companies are using convolutional neural networks to identify promising drug candidates.
AI-based wearable devices are routinely used to monitor patients, flagging up any changes to their vital signs. There are even AI-based triage tools for Covid-19, which can determine who needs a PCR test.
L'IA : opportunité ou menace ? Les DSI de la finance s'interrogent Alors que l'intelligence…
Sécurité des identités : un pilier essentiel pour la conformité au règlement DORA dans le…
La transformation numérique du secteur financier n'a pas que du bon : elle augmente aussi…
Telegram envisage de quitter la France : le chiffrement de bout en bout au cœur…
L'intelligence artificielle (IA) révolutionne le paysage de la cybersécurité, mais pas toujours dans le bon…
TISAX® et ISO 27001 sont toutes deux des normes dédiées à la sécurité de l’information. Bien qu’elles aient…
This website uses cookies.